BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumor

Ting Yu(Kunming Medical University), Ju-Lun Yang(Kunming University of Science and Technology)

PLoS ONE

June 1, 2022

10.1371/journal.pone.0269084

Cited by 9

Related Papers

Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells

|BMC Cancer|2018|21

RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480

|BMC Cancer|2021|15

RGD-p21Ras-scFv expressed prokaryotically on a pilot scale inhibits ras-driven colorectal cancer growth by blocking p21Ras-GTP

|BMC Cancer|2024|1